Topical Use Acne Treatment Market 2017: Increased Spending On Drugs From Various Emerging Economies

The new research report “Global Topical Use Acne Treatment Market” accounted to USD 4.9 billion in 2016 growing at a CAGR of 4.6% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Topical Use Acne Treatment Market, By Drug Class (Antibiotics, Anti-Inflammatory Drugs, Antimicrobial, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid), By Route of Administration (Topical, and Oral), By Type (Prescription and OTC), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

This report consists of below pages:

• No of pages: 350
• No of Figures: 60
• No of Tables: 220

Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-use-acne-treatment-market

Report Definition

Topical use acne treatment is used to reduce the severity and frequency of acne growth. Topical treatments such as retinoid, antibiotics and dapsone are used to unblock the pores and kill the bacteria making it effective for mild and severe acne treatment.

Summary of Major Market Drivers and Restraints:

• Rising disposable income
• Increased spending on drugs from various emerging economies
• Government Initiatives to better healthcare
• High global prevalence rate of acne,
• Rising health expenditures
• Stringent regulation

Market Segmentation:

By drug class the market for topical use acne treatment market report is segmented into antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid.

By route of administration the topical use acne treatment market is segmented into topical, and oral. By type the segmentation of the market is prescription and OTC Based.

Request for TOC about the Global Topical Use Acne Treatment Market Visit @ http://databridgemarketresearch.com/toc/?dbmr=global-topical-use-acne-treatment-market

On the basis of geography, topical use acne treatment market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, andBrazil among others. In 2017, North America is expected to dominate the market.

Competitive Analysis:

The global topical use acne treatment market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of topical use acne treatment market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors:

Some of the major players operating in topical use acne treatment market are:

• Foamix Pharmaceuticals
• Allergan
• Galderma
• Stiefel Laboratories, Inc.
• Valeant Pharmaceutical International Inc.
• Johnson & Johnson Private Limited
• Cipher
• Ranbaxy Laboratories
• GlaxoSmithKline
• Teva
• Ranbaxy
• Bayer AG
• Dermira
• Guthy-Renker LLC
• Reckitt Benckiser PLC
• Actavis Plc among others.

Read more news about this Report visit @ http://databridgemarketresearch.com/reports/global-topical-use-acne-treatment-market/

TABLE OF CONTENTS

1. INTRODUCTION
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL TOPICAL USE ACNE TREATMENT MARKET
2.3 GLOBAL TOPICAL USE ACNE TREATMENT MARKET:
RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY TYPES OF ACNE
6.1 OVERVIEW
6.2 ACNE VULGARIS
6.3 ACNE FULMINANS
6.4 ACNE MECHANICA
6.5 ACNE ROSACEA
6.6 PYODERMA FACIALE
6.7 ACNE CONGLOBATA
6.8 ACNE COSMETICA
6.9 ACNE KELOIDALIS NUCHAE (AKN)
6.10 CHLORACNE
6.11 ACNE MEDICAMENTOSA
7 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY DRUG
7.1 OVERVIEW
7.2 RETINOID
7.3 ANTIBIOTICS
7.4 HORMONAL AGENTS
7.5 COMBINATION MEDICATIONS
7.6 ANTI-INFLAMMATORY
7.7 OTHER AGENTS
7 GLOBAL TOPICAL USE ACNE TREATMENT MARKET,
BY MEDICATION TYPE
7.1 OVERVIEW
7.2 LIQUID
7.2.1 SOLUTIONS
7.2.2 SUSPENSIONS
7.3 SEMI-SOLID
7.3.1 GELS
7.3.2 CREAMS
7.3.3 OINTMENTS
7.3.4 PASTES
7.3.5 LOTIONS
7.4 SOLID
7.4.1 POWDERS
7.4.2 OTHERS
8 GLOBAL TOPICAL USE ACNE TREATMENT MARKET,
BY PRODUCT APPLICATION
8.1 OVERVIEW
8.2 PRESCRIPTION
8.3 OVER THE COUNTER (OTC)
9 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 HOMECARE
9.4 DERMATOLOGY CLINICS
9.5 OTHERS
10 GLOBAL TOPICAL USE ACNE TREATMENT MARKET,
BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 HOSPITAL PHARMACIES
10.3 PHARMACY STORES
10.4 ONLINE PHARMACIES
10.5 OTHERS
11 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY COUNTRY
11.1 COUNTRYWISE TOPICAL USE ACNE TREATMENT MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1.1 NORTH AMERICA
11.1.2 EUROPE
11.1.3 ASIA-PACIFIC (APAC)
11.1.4 SOUTH AMERICA
11.1.5 MIDDLE EAST AND AFRICA
11.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 GLOBAL TOPICAL USE ACNE TREATMENT MARKET:
COMPETITIVE LANDSCAPE
12.1. GLOBAL TOPICAL USE ACNE TREATMENT MARKET:
COMPANY SHARE ANALYSIS
12.2. MERGERS & ACQUISITIONS
12.3. NEW PRODUCT DEVELOPMENT & APPROVALS
12.4. EXPANSIONS
12.5. REGULATORY CHANGES
12.6. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
13 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, COMPANY PROFILES
13.1 GALDERMA S.A.
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL ANALYSIS
13.1.3 PRODUCT MATRIX
13.1.4 RECENT DEVELOPMENTS
13.1.5 DATABRIDGE ANALYSIS
13.2 ALLERGAN
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL ANALYSIS
13.2.3 PRODUCT MATRIX
13.2.4 RECENT DEVELOPMENTS
13.2.5 DATABRIDGE ANALYSIS
13.3 VALEANT
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL ANALYSIS
13.3.3 PRODUCT MATRIX
13.3.4 RECENT DEVELOPMENTS
13.3.5 DATABRIDGE ANALYSIS
13.4 GLAXOSMITHKLINE PLC. (GSK)
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL ANALYSIS
13.4.3 PRODUCT MATRIX
13.4.4 RECENT DEVELOPMENTS
13.4.5 DATABRIDGE ANALYSIS
13.5 BAYER AG
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL ANALYSIS
13.5.3 PRODUCT MATRIX
13.5.4 RECENT DEVELOPMENTS
13.5.5 DATABRIDGE ANALYSIS
13.6 AQUA PHARMACEUTICALS
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL ANALYSIS
13.6.3 PRODUCT MATRIX
13.6.4 RECENT DEVELOPMENTS
13.6.5 DATABRIDGE ANALYSIS
13.7 ESPADA DERMATOLOGY, INC
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL ANALYSIS
13.7.3 PRODUCT MATRIX
13.7.4 RECENT DEVELOPMENTS
13.7.5 DATABRIDGE ANALYSIS
13.8 NOVAN, INC.
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL ANALYSIS
13.8.3 PRODUCT MATRIX
13.8.4 RECENT DEVELOPMENTS
13.8.5 DATABRIDGE ANALYSIS
13.9 SANOFI PASTEUR SA
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL ANALYSIS
13.9.3 PRODUCT MATRIX
13.9.4 RECENT DEVELOPMENTS
13.9.5 DATABRIDGE ANALYSIS
13.10 PFIZER
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL ANALYSIS
13.10.3 PRODUCT MATRIX
13.10.4 RECENT DEVELOPMENTS
13.10.5 DATABRIDGE ANALYSIS
13.11 LEO PHARMA A/S
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL ANALYSIS
13.11.3 PRODUCT MATRIX
13.11.4 RECENT DEVELOPMENTS
13.11.5 DATABRIDGE ANALYSIS
13.12 ABBVIE INC.
13.12.1 COMPANY OVERVIEW
13.12.2 FINANCIAL ANALYSIS
13.12.3 PRODUCT MATRIX
13.12.4 RECENT DEVELOPMENTS
13.12.5 DATABRIDGE ANALYSIS
13.13 ACLARIS THERAPEUTICS, INC.
13.13.1 COMPANY OVERVIEW
13.13.2 FINANCIAL ANALYSIS
13.13.3 PRODUCT MATRIX
13.13.4 RECENT DEVELOPMENTS
13.13.5 DATABRIDGE ANALYSIS
13.14 ASTELLAS PHARMA INC.
13.14.1 COMPANY OVERVIEW
13.14.2 FINANCIAL ANALYSIS
13.14.3 PRODUCT MATRIX
13.14.4 RECENT DEVELOPMENTS
13.14.5 DATABRIDGE ANALYSIS
13.15 GLENMARK
13.15.1 COMPANY OVERVIEW
13.15.2 FINANCIAL ANALYSIS
13.15.3 PRODUCT MATRIX
13.15.4 RECENT DEVELOPMENTS
13.15.5 DATABRIDGE ANALYSIS

Related Report

Global Cancer Biomarkers Market – Industry Trends and Forecast to 2024

Global Cancer Biomarkers Market, By Tumor (Breast, Lung, Prostate), By Type (Protein Biomarker, Genetic Biomarkers), By Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), By Application (Diagnostic, Drug Discovery, Prognostic), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-cancer-biomarkers-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.